These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28932273)

  • 21. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sense of coherence and quality of life in women with and without irritable bowel syndrome.
    Motzer SA; Hertig V; Jarrett M; Heitkemper MM
    Nurs Res; 2003; 52(5):329-37. PubMed ID: 14501547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
    Andrae DA; Covington PS; Patrick DL
    Clin Ther; 2014 May; 36(5):663-79. PubMed ID: 24813429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.
    Andrae DA; Patrick DL; Drossman DA; Covington PS
    Health Qual Life Outcomes; 2013 Dec; 11():208. PubMed ID: 24330412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spectrum of irritable bowel syndrome: A clinical review.
    Gilkin RJ
    Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical activity for treatment of irritable bowel syndrome.
    Nunan D; Cai T; Gardener AD; Ordóñez-Mena JM; Roberts NW; Thomas ET; Mahtani KR
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD011497. PubMed ID: 35766861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.
    Sayuk GS; Wolf R; Chang L
    Am J Gastroenterol; 2017 Jun; 112(6):892-899. PubMed ID: 28094313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: the economic impact of the irritable bowel syndrome.
    Canavan C; West J; Card T
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1023-34. PubMed ID: 25199904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on Pharmacotherapy for Irritable Bowel Syndrome.
    Munjal A; Dedania B; Cash B
    Curr Gastroenterol Rep; 2019 Apr; 21(6):25. PubMed ID: 31025114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cilansetron: KC 9946.
    Drugs R D; 2005; 6(3):169-73. PubMed ID: 15869320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
    Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
    Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population.
    Tornkvist NT; Aziz I; Whitehead WE; Sperber AD; Palsson OS; Hreinsson JP; Simrén M; Törnblom H
    United European Gastroenterol J; 2021 Dec; 9(10):1178-1188. PubMed ID: 34599559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome.
    Windgassen S; Moss-Morris R; Chilcot J; Sibelli A; Goldsmith K; Chalder T
    Br J Health Psychol; 2017 Nov; 22(4):701-736. PubMed ID: 28573818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Comparison of WHOQOL-BREF with Disease Specific Heath Related Quality of Life Questionnaire in Irritable Bowel Syndrome.
    Jamali R; Biglari M
    Acta Med Iran; 2015 Nov; 53(11):717-24. PubMed ID: 26786994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irritable bowel syndrome: Factors of importance for disease-specific quality of life.
    Melchior C; Colomier E; Trindade IA; Khadija M; Hreinsson JP; Törnblom H; Simrén M
    United European Gastroenterol J; 2022 Sep; 10(7):754-764. PubMed ID: 35830193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea.
    Abel JL; Carson RT; Andrae DA
    Qual Life Res; 2019 Feb; 28(2):369-377. PubMed ID: 30267294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis.
    Estremera-Arevalo F; Barcelo M; Serrano B; Rey E
    World J Gastroenterol; 2019 Feb; 25(7):837-847. PubMed ID: 30809083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Content, face, and construct validity of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) as a measure of bowel-related quality of life in spinal cord injury.
    Abedi A; Kohli P; Montero S; Morales L; Ha N; Abedi A; La Riva A; Ginsberg D; Kreydin E
    Neurourol Urodyn; 2023 Aug; 42(6):1362-1373. PubMed ID: 37166006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.